Targeting B7-H3 (CD276) in neuroblastoma: In vitro evaluation of Fc-optimized antibodies and immunocytokines

被引：2
|
作者：
Heubach, Florian
Schlegel, Patrick
Zekri, Latifa
Manz, Timo
Schleicher, Sabine
Rabsteyn, Armin
Jung, Gundram
Buehring, Hans-Joerg
Gillies, Stephen D.
Handgretinger, Rupert
Lang, Peter
机构：
[1] Childrens Univ Hosp, Tubingen, Germany
[2] Eberhard Karls Univ Tubingen, Tubingen, Germany
[3] German Canc Consortium DKTK, Tubingen, Germany
[4] German Canc Res Ctr, Tubingen, Germany
[5] Provenance Biopharmaceut, Carlisle, MA USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A131
引用
收藏
页数：2
相关论文
共 50 条
  • [31] B7-H3 (CD276) immunocytokines with target-cell restricted IL-15 activity for induction of anti-tumor immunity against leukemia and gastrointestinal tumors
    Schmied, B. J.
    Zekri-Metref, L.
    Maerklin, M.
    Pfluegler, M.
    Buehring, H. -J.
    Handgretinger, R.
    Kanz, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 240 - +
  • [32] Diversity in B7-H3/CD276 expression across cancer types: Exploring a dynamic novel immune checkpoint.
    Larkin, Brigid
    Nishizaki, Daisuke
    Miyashita, Hirotaka
    Lee, Suzanna
    Nikanjam, Mina
    Nesline, Mary K.
    Pabla, Sarabjot
    Conroy, Jeffrey M.
    DePietro, Paul
    Sicklick, Jason K.
    Kurzrock, Razelle
    Kato, Shumei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
    Hagelstein, Ilona
    Engel, Monika
    Hinterleitner, Clemens
    Manz, Timo
    Maerklin, Melanie
    Jung, Gundram
    Salih, Helmut R.
    Zekri, Latifa
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer
    Li, Jia
    Wang, Dongxu
    Zhang, Chenxin
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [35] Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
    Zhou, Yiran
    Zhou, Haodong
    Shi, Jianlin
    Guan, Aoran
    Zhu, Yankun
    Hou, Zongliu
    Li, Ruhong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [36] mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
    Liu, Heng-Jia
    Du, Heng
    Khabibullin, Damir
    Zarei, Mahsa
    Wei, Kevin
    Freeman, Gordon J.
    Kwiatkowski, David J.
    Henske, Elizabeth P.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [37] Expression of B7-H3 (CD276) an Immunoregulatory Cell Surface Molecule in Non-Hodgkin Lymphomas Identified by Mass Spectrometry
    Wey, E. A.
    Laliberta, J.
    McNeil, C.
    Basrur, V.
    Keyoumarsi, F.
    Thomas, D.
    Suh, C.
    Huh, J.
    Elenitoba-Johnson, K.
    Linz, M. S.
    MODERN PATHOLOGY, 2011, 24 : 329A - 329A
  • [38] Expression of B7-H3 (CD276) an Immunoregulatory Cell Surface Molecule in Non-Hodgkin Lymphomas Identified by Mass Spectrometry
    Wey, E. A.
    Laliberta, J.
    McNeil, C.
    Basrur, V.
    Keyoumarsi, F.
    Thomas, D.
    Suh, C.
    Huh, J.
    Elenitoba-Johnson, K.
    Lim, M. S.
    LABORATORY INVESTIGATION, 2011, 91 : 329A - 329A
  • [39] mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
    Heng-Jia Liu
    Heng Du
    Damir Khabibullin
    Mahsa Zarei
    Kevin Wei
    Gordon J. Freeman
    David J. Kwiatkowski
    Elizabeth P. Henske
    Nature Communications, 14
  • [40] A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155
    Husain, Bushra
    Ramani, Sree R.
    Chiang, Eugene
    Lehoux, Isabelle
    Paduchuri, Sairupa
    Arena, Tia A.
    Patel, Ashka
    Wilson, Blair
    Chan, Pamela
    Franke, Yvonne
    Wong, Athena W.
    Lill, Jennie R.
    Turley, Shannon J.
    Gonzalez, Lino C.
    Grogan, Jane L.
    Martinez-Martin, Nadia
    MOLECULAR & CELLULAR PROTEOMICS, 2019, 18 (11) : 2310 - 2323
12345